New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2018, WHO recommendations Uterotonics for the prevention of postpartum haemorrhage
View latest version (2018)Bibliographic Info
GuidelineWHO recommendations for the prevention and treatment of postpartum haemorrhage
Year of Publication2012
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
In settings where oxytocin is unavailable, the use of other injectable uterotonics (if appropriate ergometrine/methylergometrine or the fixed drug combination of oxytocin and ergometrine) or oral misoprostol (600 µg) is recommended (for the prevention of postpartum haemorrhage)
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO recommendations: intrapartum care for a positive childbirth experience
Year2018
InstitutionWorld Health Organization